CANIDOL PHARMACEUTICS
CANIDOL Pharmaceutics is a group of organisations in the healthcare, research and pharmacy sector. Establishing and pioneering products to help give access to a wide range of high quality pharmaceutical grade cannabinoid-based products.
The products are not for general sale. They’re recommended or prescribed by healthcare professionals registered with UK Cannabis Clinic.
Canidol Phamaceutics are constantly evolving to provide the best care for patients.
UK Cannabis Clinic is a service for the medical and pharmacy community to help with the supply, education and information relating to the supply of Cannabis products. The company provides help training and support to medical professionals.
CANIDOL Products
Canidol is a pure cannabidiol product produced as a novel product with a structured and consistant purity. The product is supplied by Canidol Pharmaceutics
The range includes full spectrum retail products and potent single molecule prescription products. Derived entirely from natural sources developed using traditional methods.
It is independently verified to contain no trace of THC and is presented in a low flavour inert base.
Our
Canidol Current Research

1 of 8
Chronic Fatigue and Auto Immune
Our aim is to retrospectively analyse patient events, where supply events have occurred to patients who have pain caused by an underlying inflammatory disease.

2 of 8
Bowel Disease IBD
Our aim in this arm of the research is to capture patients with self-reported conditions, currently on no or standard therapy, and see whether cannabidiol provides a safe extension to the period of remission.

3 of 8
Inflammatory Pain Conditions
Our aim is to capture data from patients who have switched from THC containing cannabis products, to non-THC cannabis products – and determine if the efficacy and symptom control are similar.

4 of 8
Multiple Sclerosis
Our aim is to capture data from patients who have switched from THC containing cannabis products, to non-THC cannabis products – and determine if the efficacy and symptom control are similar.

5 of 8
Hospice Care
Currently, a reportedly huge problem facing hospices and oncology wards worldwide, is that patients are obtaining illegal cannabis preparations and taking them into hospital.

6 of 8
Pediatric Use
The aim of this set of research is not to determine efficacy, but to determine if there is a dose/side effect profile in paediatric patients under the direct care of a consultant paediatrician.

7 of 8
Oncology and Cancer
Under the direction of our consultant oncologists, the aim is to examine data based on supplies of cannabinoids made to patients - using standardised dosing - extrapolated from in-vitro studies.

8 of 8
Historical Research
Our aim is to capture data from patients who have switched from THC containing cannabis products, to non-THC cannabis products – and determine if the efficacy and symptom control are similar.

Knowledgebase and training
Training and knowledge are important to us.
In order to make appropriate clinical decisions, health professionals should complete an appropriate training on potential pharmacokinetic and pharmacodynamic interactions.
While none of our products make any medical claims, health professionals must complete relevant training on the medical condition’s patients will present with.
While Cannabidiols are natural and safe to use, they can potentially affect other medications patients may be taking.
Testimonials
What Canidol
patients say
Reported conditions
Our patients have taken or have been prescribed cannabinoids for a great number of diseases. These include:
- Epilepsy / anti-seizure
- Multiple Sclerosis
- ALS
- Arthritis
- Lyme Disease
- Hashimoto’s Thyroiditis
- ME and associated conditions
- Certain Cancers
- Mental Health
- Diabetes
- Acne
- Sleep disorders
- Alzheimer’s
- Parkinson’s
